Abstracts tagged "Gene Expression and Sjӧgrens"

Abstract Number: 2982 • 2014 ACR/ARHP Annual Meeting
Identification of Whole Blood Gene Expression Signature in Primary Sjögren’s Syndrome Associated Lymphoma
Shereen Al-Ali^1,2, Simon Cockell³, Andrew Skelton⁴, Katherine James¹, Jessica Tarn¹, David Young⁵, Bridget Griffiths⁶, Simon Bowman⁷, James Locke¹ and Wan-Fai Ng⁸, ¹Newcastle University, Newcastle upon Tyne, United Kingdom, ²College of Science, University of Basrah, Basrah, Iraq, ³Bioinformatics Support Unit, Newcastle University, Newcastle upon Tyne, United Kingdom, ⁴Bioinformatics support unit, Newcastle University, Newcastle Upon Tyne, United Kingdom, ⁵Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom, ⁶Rheumatology, Freeman Hospital, Newcastle Upon Tyne, United Kingdom, ⁷Rheumatology Dept (Selly Oak), University Hospital Birmingham, Birmingham, United Kingdom, ⁸Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
Background/Purpose: Primary Sjӧgren’s syndrome (pSS) is associated with a substantially increased risk of lymphoma development. The aim of our study is to identify a whole…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].